Recent research have focused on the overlap of GLP|GIP|GCGR agonist therapies and DA neurotransmission. While GCGR stimulators are commonly employed for managing type 2 T2DM, their unexpected effects on motivation https://janefgxe069742.full-design.com/novel-gcgr-agonists-and-da-influence-a-relative-overview-84214579